Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia  by Jiang, Wujun et al.
b r a z j i n f e c t d i s . 2 0 1 4;1  8(2):124–128
The Brazilian Journal of
INFECTIOUS  DISEASES
www.elsev ier .com/ locate /b j id
Original article
Clinical  signiﬁcance  of  different  bacterial  load  of
Mycoplasma pneumoniae  in patients  with Mycoplasma
pneumoniae pneumonia
Wujun Jiang, Yongdong Yan ∗, Wei Ji, Yuqing Wang, Zhengrong Chen
Department of Respiratory Medicine, Children’s Hospital Afﬁliated to Soochow University, China
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 3 April 2013
Accepted  12 June 2013
Available  online 26 October 2013
Keywords:
Mycoplasma pneumoniae
Pneumonia
Polymerase chain reaction
Serology
a  b  s  t  r  a  c  t
Objective: This retrospective study was conducted to investigate the clinical signiﬁcance of
different Mycoplasma pneumoniae bacterial load in patients with M. pneumoniae pneumonia
(MP)  in children.
Methods: Patients with MP (n = 511) were identiﬁed at the Children’s Hospital Afﬁliated to
Soochow  University database during an outbreak of MP between January 2012 and February
2013.
Results:  Comparing patients with high and low bacterial load those with higher loads were
signiﬁcantly  older (p < 0.01) and had fever signiﬁcantly more frequently (p = 0.01). Presence
of  wheezing at presentation was associated with low bacterial load (p = 0.03). Baseline posi-
tive  IgM was present in 93 (56.4%) patients with high bacterial load compared to 46 (27.8%)
patients  with low bacterial load (p < 0.001). Co-infection with viruses was found signiﬁ-
cantly  more  frequent among patients with low bacterial load (24.2%) than those with high
bacterial  load (8.5%) [p < 0.001]. Bacterial co-infection was also more  frequently detected
among  patients with low bacterial load (22.4%) than in those with high bacterial load (12.1%)
[p  = 0.01].Conclusion: M. pneumoniae at a high bacterial load could be an etiologic agent of respira-
tory  tract disease, whereas the etiologic role of MP at a low bacterial load remains to be
determined.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDIntroductionMycoplasma pneumoniae is an important pathogen respon-
sible  for community-acquired pneumonia in children.
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Este é um artigo Open Access sob a licença M.  pneumoniae pneumonia (MP) has been reported in 10–40%
1–4ildren’s Hospital Afﬁliated to Soochow University, No. 303 Jing De
of  community-acquired pneumonia cases. The mainstay
for  diagnosing of M.  pneumoniae infection presently relies on
a  rise in paired titer by serological methods.5 Polymerase
chain reaction (PCR) has been applied for the early detection
de CC BY-NC-ND
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918  patients who were  not diagnosed with MP  did not differ
signiﬁcantly from patients with MP in terms of sex and age at
disease  onset.
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f M.  pneumoniae infection.6,7 The role of PCR assays per-
ormed on upper respiratory tract samples for the diagnosis
f  M.  pneumoniae infection is controversial.5,8 Previous study
emonstrated that PCR can detect persistent M. pneumoniae
nfection up to 7 months after disease onset, the bacterial
oad  in consecutive samples gradually declined in relation to
he time interval from onset of illness to sampling.9 Thus, the
linical  signiﬁcance of different M. pneumoniae bacterial load
s  of much  interest.
This  study was  conducted to investigate the clinical sig-
iﬁcance  of different M. pneumoniae bacterial load using
asopharyngeal aspirates (NPAs) during a recent outbreak of
P  in children.
aterials  and  methods
atients  and  specimens
his study was  a retrospective analysis of real-time PCR for
iagnostic  testing of M.  pneumoniae infection by antigen detec-
ion.  Patients hospitalized with clinically and radiologically
onﬁrmed lower respiratory tract infections (n = 1429) were
dentiﬁed  at the Children’s Hospital Afﬁliated to Soochow Uni-
ersity  database during an outbreak of MP between January
012  and February 2013. Both serum and NPAs were  obtained
rom  these patients. Therefore, patients without stored serum
amples  or results of NPAs were excluded from our study.
aired  serum samples taken on admission and at least seven
ays  after the ﬁrst collection were  available for 733 patients
51.3%).
eal-time  PCR
asopharyngeal swabs were obtained within 24 h of admis-
ion.  The specimens were centrifuged and were stored at
80 ◦C until tested. A quantitative diagnostic kit (DaAn Gene
o.,  Ltd., Guangzhou, China) for M. pneumoniae DNA was
sed  to determine the load of MP,  as previously reported.10
he method is based on the TaqMan PCR technology, and
he  target is 16S rRNA gene speciﬁc for MP genome. Brieﬂy,
 mL  of nasopharyngeal aspirates diluted with 4% NaOH was
entrifuged  at 12,000 rpm for ﬁve min. The sediment was col-
ected,  washed twice with 0.9% NaCl, blended with 50 L of
NA  extraction solution, incubated at 100 ◦C for 10 min, and
entrifuged  at 12,000 rpm for ﬁve min. Real-time PCR was per-
ormed  on the resulting supernatant with 2 L, and PCR mix
ith  43 L (supplied with the kits) using the DA 7600 real-time
CR  system (Applied Biosystems, California, USA) as follows:
3 ◦C for 2 min, 10 cycles of 93 ◦C for 45 s and 55 ◦C for 60 s,
ollowed by 30 cycles of 93 ◦C for 30 s and 55 ◦C for 45 s. All
asopharyngeal swabs were tested for antigen detection by
mmunoﬂuorescence for seven common viruses (RSV, adeno-
irus,  inﬂuenza viruses A and B, and parainﬂuenza viruses 1,
 and 3).erology
etection of serum M. pneumoniae-speciﬁc antibody was
erformed using enzyme-linked immunosorbent assay4;1 8(2):124–128  125
(Virion-Serion, Germany). The assay was considered positive
if  IgM ≥ 1.1 or if there was  ≥4-fold rise in IgG titer.8
Diagnosis  of  MP
Diagnosis of MP was based on serology or PCR ﬁndings. A
signiﬁcant  rise in M. pneumoniae IgG titer or the presence of
IgM  antibodies was used as criteria for current M.  pneumoniae
infection. Likewise, DNA detection by real-time PCR was  also
considered  M.  pneumoniae infection.
Review  of  medical  records
Data compiled from a retrospective chart review of all study
patients  were extracted through the use of specially pre-
pared  data forms without knowledge of serologic status or
PCR  results. The information extracted included demograph-
ics,  clinical features and laboratory data.
Statistical  analysis
We  used n (%) for categorical variables and median (IQR) for
continuous  variables with non-normal distribution or mean
(SD)  for those with normal distribution. We assessed differ-
ences  in categorical variables with the 2 test. We calculated
95%  CI for differences in medians with an exact test. Logis-
tic  regression analysis was  performed to identify clinical
characteristics associated with different bacterial loads. SPSS
(version  17.0) software was used for all statistical analysis.
Results
Demographic  ﬁndings
Among 1429 patients with lower respiratory tract infections,
511  (35.8%) were  diagnosed with MP based on serology or PCR
ﬁndings.  Of the 511 patients with MP, 304 (59.5%), the mean
age  was 35 months (range, one month to 156 months). The age
distribution  of the patients is shown in Fig. 1. The remaining0 21 3 4 5 6 7 8 9 10 11 12 13
Ages
Fig. 1 – Age distribution of our patients.
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Fig. 2 – Distribution of different bacterial loads in our
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Fig. 4 – Monthly occurrence of total episodes of Mycoplasma
pneumoniae pneumonia and cases with different bacterialpatients.
Quantitative  analysis  of  M.  pneumoniae  DNA  in
nasopharyngeal  aspirates
Of the 511 patients with MP,  PCR for M.  pneumoniae was  posi-
tive  in 330 (64.6%) nasopharyngeal samples. Genomal bacterial
load  in NPAs ranged from <2500 to >2.5 × 107 copies/mL of
sampled  material. According to the distribution of genomal
bacterial  loads (Fig. 2), patients were  classiﬁed into two groups:
high  bacterial load group (>107 copies/mL) (n = 165) and low
bacterial  load (<107 copies/mL) (n = 165).
The  genomal bacterial load increased signiﬁcantly with age
(p  < 0.001). Fewer Children younger than one year of age had
less  high bacterial load (17.7%) than those older than ﬁve years
(53.8%)  [p < 0.001] (Fig. 3).
Epidemiology  of  MP  outbreak
Seasonal distribution of MP  according to genomal bacterial
load  is shown in Fig. 4.
Outbreaks began in summer months and peaked during
August and September (73.5% of all MP  cases). The frequency
of  patients with high bacterial load also increased during sum-
mer  and peaked in August and September. From January to
March  18 (15%) MP  patients had high bacterial load, com-
pared  to 52 (27.5%) from April to June, 137 (43.3%) from July
to  September, and 96 (38.7%) from October to December.
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Fig. 3 – Different bacterial loads individuals categorized
according to age group.loads  during the outbreaks in 2012.
Comparison  of  clinical  characteristics  by  PCR  status
Clinical characteristics according to PCR status are summa-
rized  in Table 1. To assess the independent association of
evaluated  parameters, mean age, fever, and wheezing at pre-
sentation  were tested by logistic regression analysis. Patients
with  high bacterial load were signiﬁcantly older (p < 0.01) and
had  signiﬁcantly higher fever (p = 0.01). Wheezing at presenta-
tion  was  associated with low bacterial load (p = 0.03).
Comparison  of  serological  tests  by  PCR  status
Out of 330 PCR positive children, 179 patients had paired
serum  samples. No difference was found in the interval
between onset of symptoms and the time of obtaining the ﬁrst
serum  sample or second serum sample. 93 (56.4%) patients
with  high bacterial load 46 (27.8%) had more  initial positive
IgM  compared to patients with low bacterial load (p < 0.001).
Geometric mean titers of initial IgG and IgM of patients with
high  bacterial load were not signiﬁcantly different from those
of  patients with low load. In patients with low bacterial load,
geometric  mean titers of second IgG signiﬁcantly increased
compared with the initial IgG in patients more  than ﬁve years
old.  In patients with high bacterial load, geometric mean
titers  of second IgG signiﬁcantly increased in younger patients
(Fig.  5). Patients with high bacterial load also had geometric
mean titers of second IgM signiﬁcantly increased in younger
patients  compared with patients with low bacterial load.
Comparison  of  co-infection  by  PCR  status
Co-infections were detected in 204 patients with MP  (102 with
virus  and 102 with bacteria). Co-infection with viruses was
signiﬁcantly more  frequent among patients with low bacte-
rial  load than those with high bacterial load (24.2% vs. 8.5%;
p  < 0.001). Bacterial co-infections were also more  frequently
detected among patients with low bacterial load than in those
with  high bacterial load (22.4% vs. 12.1%; p = 0.01).
DiscussionThis study investigated the diagnostic values and clinical
signiﬁcance of real-time PCR in children during an epidemic of
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Table 1 – Clinical characteristics according to PCR status in patients with MP.
Characteristics Genomal bacterial load
PCR negative (n = 181) Low load (n = 165) High load (n = 165)
Male:female (n) 109:72  100:65 95:70
Mean age (months)a 26 (29) 29  (31) 49  (54)b,d
Duration of prior symptoms (days)a 7.6 (2.5) 7.5 (5.0) 7.2 (3.7)
Antibiotic therapy within 2 weeks preceding admission, n (%) 141 (77.9) 81 (84.4) 135 (81.8)
Fever (Tmax ≥ 38.5 ◦C), n (%) 111 (61.3) 97 (58.7) 127 (77.0)c,d
Wheezing at presentation, n (%) 56 (30.9) 59 (35.8) 26 (15.8)c,d
a Data expressed as means (SD).
b p < 0.01 compared with low genomal bacterial load.
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d Mean age, fever, and wheezing at presentation were tested by logis
.  pneumoniae infection in 2012. M. pneumoniae at a high load
as  more  frequently detected in older children and more
trongly  associated with fever, but inversely associated with
heezing.  In addition, positive initial IgM and signiﬁcantly
ncreased second antibody titers were  detected more  often
n  patients with high bacterial load, which indicated that
igh  bacterial load was  associated with increased humoral
esponse.
Various  tests have been used to detect MP infection. The
ainstay  for diagnosing of M.  pneumoniae infection presently
elies  on a rise in Ig titers in paired serum samples.5 How-
ver,  during the early phase of MP  infection, particularly in
oung  children and immunocompromised patients, serologi-
al  methods have low sensitivity.10,11 In contrast, PCR seemed
o  be a sensitive, high-throughput and rapid method.12,13
nterestingly, the data presented here demonstrated that the
umber  of children with high bacterial load increased with
he  age. Only 17.7% of the children with MP younger than one
ear  had high genomal bacterial load, but 53.8% of the chil-
ren  older than ﬁve years had high load. Our study also found
hat  positive initial IgM were detected more  often in patients
ith  high bacterial load (56.4% vs. 27.8%). In addition, patients
ith  low bacterial load did neither have IgM or IgG increase in
he less than one-year and one to four-year-old group when
erum  paired samples were  available.From culture based studies, it is known that the ﬁrst step
n  the pathogenic process of M. pneumoniae involves cytoad-
erence  between M.  pneumoniae and respiratory epithelium.
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After  adherence, M. pneumoniae needs to replicate in order
to  establish an infection, involving colonization and inﬂam-
mation  in human tissues.14 The above ﬁndings suggest that
in  young children M.  pneumoniae colonization is usually weak
which  leads to poor antigenic stimulation. These could explain
why  antibody response to M.  pneumoniae is weak or deferred
in  young children because of poor antigenic stimulation from
another  prospective.
Nilsson et al.9 found that the bacterial load in consecu-
tive samples gradually declined in relation to the time interval
from  onset of illness to sampling. Infections associated with
low  bacterial load may  reﬂect M. pneumoniae persistence. In
our  study, 42.1% of the PCR positive children were  seroposi-
tive.  Most of these seropositive diagnoses (93 out of 139, 66.9%)
occurred  in children with high bacterial load. High bacterial
load  was  noted mainly in the absence of other respiratory
viral or bacterial infections, suggesting a causative role of
MP.  However, low bacterial load was detected more  often in
viral  co-infection and more  strongly associated with wheez-
ing,  suggesting that a low bacterial load in the nasopharynx
seems to be of little clinical signiﬁcance. Besides, as M. pneu-
moniae  replicates slowly and has limited capacity for protein
biosynthesis, the above ﬁnding may  also suggest that the
presence  of respiratory viruses may  reduce M. pneumoniae col-
onization. However, we were unable to conﬁrm whether this
happened  in older children due to the low proportion of mixed
infections  in age group (3.4% in patients greater than three
years).
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PCR tests also have their drawbacks. They could not
distinguish between viable and nonviable organisms after
antibacterial therapy.15–17 Also, concerns exist about the
potential inability to distinguish between respiratory car-
riage  vs. active disease.17 Prescribing macrolides in the
presence of a positive PCR assay may  increase the unneces-
sary  use of macrolides. According to our study, prescribing
macrolides based on a positive PCR in patients with low
bacterial  load and serologically negative should be carefully
considered.
The  ﬁndings of the present study have some limitations.
The patients included were hospitalized cases of pneumo-
nia.  We  did not enroll patients with other spectrum of acute
respiratory illnesses. Therefore, patients with more severe
symptoms  may  have been overrepresented. The patients were
also more  likely to have received antibiotic treatment due to
the clinical manifestations.
In  conclusion, our results suggest that M. pneumoniae at
a  high bacterial load could be an etiologic agent of respira-
tory  tract disease, whereas the etiologic role of MP  at a low
bacterial  load remains to be determined. Quantitative analy-
sis  may,  therefore, be important for studies of M. pneumoniae
infection.
Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
 e  f  e  r  e  n  c  e  s
1. Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T,
et al. Epidemiology and clinical characteristics of
community-acquired pneumonia in hospitalized children.
Pediatrics. 2004;113:701–7.
2. Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma
pneumoniae and Chlamydia pneumoniae in children with
community-acquired lower respiratory tract infections. Clin
Infect  Dis. 2001;32:1281–9.
3. Nolevaux G, Bessaci-Kabouya K, Villenet N, Andreoletti L,
Laplanche  D, Carquin J, et al. Epidemiological and clinical
study  of Mycoplasma pneumoniae respiratory infections in
children  hospitalized in a pediatric ward between 1999 and
2005  at the Reims University Hospital. Arch Pediatr.
2008;15:1630–6.
4. Juven T, Mertsola J, Waris M, Leinonen M, Meurman O,
Roivainen M, et al. Etiology of community-acquired
pneumonia in 254 hospitalized children. Pediatr Infect Dis J.
2000;19:293–8.
5. Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M,
et  al. British Thoracic Society guidelines for the management 1 4;1  8(2):124–128
of community acquired pneumonia in children: update 2011.
Thorax.  2011;66 Suppl 2:ii1–23.
6.  Hardegger D, Nadal D, Bossart W,  Altwegg M, Dutly F. Rapid
detection  of Mycoplasma pneumoniae in clinical samples by
real-time  PCR. J Microbiol Methods. 2000;41:45–51.
7. Morozumi M, Ito A, Murayama SY, Hasegawa K, Kobayashi R,
Iwata  S, et al. Assessment of real-time PCR for diagnosis of
Mycoplasma  pneumoniae pneumonia in pediatric patients. Can
J  Microbiol. 2006;52:125–9.
8. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER,
Harrison C, et al. The management of community-acquired
pneumonia in infants and children older than 3 months of
age:  clinical practice guidelines by the Pediatric Infectious
Diseases Society and the Infectious Diseases Society of
America.  Clin Infect Dis. 2011;53:e25–76.
9.  Nilsson AC, Bjorkman P, Persson K. Polymerase chain reaction
is superior to serology for the diagnosis of acute Mycoplasma
pneumoniae infection and reveals a high rate of persistent
infection. BMC Microbiol. 2008;8:93.
0.  He XY, Wang XB, Zhang R, Yuan ZJ, Tan JJ, Peng B, et al.
Investigation of Mycoplasma pneumoniae infection in pediatric
population from 12,025 cases with respiratory infection.
Diagn Microbiol Infect Dis. 2013;75:22–7.
1.  Kim NH, Lee JA, Eun BW, Shin SH, Chung EH, Park KW, et al.
Comparison of polymerase chain reaction and the indirect
particle agglutination antibody test for the diagnosis of
Mycoplasma pneumoniae pneumonia in children during two
outbreaks.  Pediatr Infect Dis J. 2007;26:
897–903.
2. Thurman KA, Warner AK, Cowart KC, Benitez AJ, Winchell JM.
Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae,
and  Legionella spp. in clinical specimens using a single-tube
multiplex real-time PCR assay. Diagn Microbiol Infect Dis.
2011;70:1–9.
3. Thurman KA, Walter ND, Schwartz SB, Mitchell SL, Dillon MT,
Baughman  AL, et al. Comparison of laboratory diagnostic
procedures for detection of Mycoplasma pneumoniae in
community outbreaks. Clin Infect Dis. 2009;48:1244–9.
4. Lee KY. Pediatric respiratory infections by Mycoplasma
pneumoniae. Expert Rev Anti Infect Ther. 2008;6:509–21.
5. Kashyap B, Kumar S, Sethi GR, Das BC, Saigal SR. Comparison
of  PCR, culture & serological tests for the diagnosis of
Mycoplasma pneumoniae in community-acquired lower
respiratory tract infections in children. Indian J Med Res.
2008;128:134–9.
6. Nadal D, Bossart W,  Zucol F, Steiner F, Berger C, Lips U, et al.
Community-acquired pneumonia in children due to
Mycoplasma pneumoniae: diagnostic performance of a
seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis.
2001;39:15–9.
7. Michelow IC, Olsen K, Lozano J, Duffy LB, McCracken GH,
Hardy  RD. Diagnostic utility and clinical signiﬁcance of naso-
and  oropharyngeal samples used in a PCR assay to diagnose
Mycoplasma pneumoniae infection in children with
community-acquired pneumonia. J Clin Microbiol.
2004;42:3339–41.
